A phase I study of combined docetaxel and repeated high activity186Re-HEDP in castration-resistant prostate cancer (CRPC) metastatic to bone (the TAXIUM trial)
Joyce M. van Dodewaard-de Jong, John M. H. de Klerk, Haiko J. Bloemendal, Bart P. J. van Bezooijen, Marie J. de Haas, Richard H. Wilson, Joe M. O’SullivanТом:
38
Мова:
english
Сторінки:
9
DOI:
10.1007/s00259-011-1883-0
Date:
November, 2011
Файл:
PDF, 136 KB
english, 2011